$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
糖尿病患者患帕金森症的风险较高
2025-10-19 11:44:20
Check Details
糖尿病新药疗效积极
2025-10-19 11:44:20
Check Details
降压药治疗1型糖尿病
2025-10-19 11:44:20
Check Details
新型降糖药补充新药申请审查延迟
2025-10-19 11:44:20
Check Details
糖尿病的严重危害
2025-10-19 11:44:20
Check Details
糖尿病临床试验结果公布
2025-10-19 11:44:20
Check Details
达格列净糖尿病心血管预后研究结果公布
2025-10-19 11:44:20
Check Details
二型糖尿病新药曲格列汀使用时需注意哪些?
2025-10-19 11:44:20
Check Details
曲格列汀不适合哪些患者服用?
2025-10-19 11:44:20
Check Details
曲格列汀治疗2型糖尿病优于安慰剂
2025-10-19 11:44:20
Check Details
曲格列汀国内有卖吗?
2025-10-19 11:44:20
Check Details
曲格列汀适用于哪些人群?
2025-10-19 11:44:20
Check Details
1
2
...
5336
5337
5338
5339
5340
5341
5342
...
10218
10219
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
2
Lemborexant: Mechanism of Action and Clinical Profile of a Dual Orexin Receptor Antagonist
3
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
4
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
5
Mechanism and Clinical Value of Pemafibrate in Triglyceride Lowering
6
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
7
Pegloticase (Krystexxa) Complete Medication Guide
8
Vemurafenib (Zelboraf) Complete Medication Guide
9
Guide to Long-Term Ramipril Use: Safety and Renal Function Management
10
Mechanism and Clinical Positioning of Leflunomide: A Comprehensive Guide to csDMARDs
11
Comprehensive Clinical Guide to Risankizumab (Skyrizi): Dosing, Contraindications, and Safety
12
Management Strategies and Long-Term Outcomes Following 6 Months of Pegloticase (Krystexxa) Therapy